Focal degeneration of astrocytes in amyotrophic lateral sclerosis - PubMed (original) (raw)
. 2008 Nov;15(11):1691-700.
doi: 10.1038/cdd.2008.99. Epub 2008 Jul 11.
Affiliations
- PMID: 18617894
- DOI: 10.1038/cdd.2008.99
Focal degeneration of astrocytes in amyotrophic lateral sclerosis
D Rossi et al. Cell Death Differ. 2008 Nov.
Abstract
Astrocytes emerge as key players in motor neuron degeneration in Amyotrophic Lateral Sclerosis (ALS). Whether astrocytes cause direct damage by releasing toxic factors or contribute indirectly through the loss of physiological functions is unclear. Here we identify in the hSOD1(G93A) transgenic mouse model of ALS a degenerative process of the astrocytes, restricted to those directly surrounding spinal motor neurons. This phenomenon manifests with an early onset and becomes significant concomitant with the loss of motor cells and the appearance of clinical symptoms. Contrary to wild-type astrocytes, mutant hSOD1-expressing astrocytes are highly vulnerable to glutamate and undergo cell death mediated by the metabotropic type-5 receptor (mGluR5). Blocking mGluR5 in vivo slows down astrocytic degeneration, delays the onset of the disease and slightly extends survival in hSOD1(G93A) transgenic mice. We propose that excitotoxicity in ALS affects both motor neurons and astrocytes, favouring their local interactive degeneration. This new mechanistic hypothesis has implications for therapeutic interventions.
Similar articles
- Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G. Milanese M, et al. Neurobiol Dis. 2014 Apr;64:48-59. doi: 10.1016/j.nbd.2013.11.006. Epub 2013 Dec 19. Neurobiol Dis. 2014. PMID: 24361555 - In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
Bonifacino T, Cattaneo L, Gallia E, Puliti A, Melone M, Provenzano F, Bossi S, Musante I, Usai C, Conti F, Bonanno G, Milanese M. Bonifacino T, et al. Neuropharmacology. 2017 Sep 1;123:433-445. doi: 10.1016/j.neuropharm.2017.06.020. Epub 2017 Jun 21. Neuropharmacology. 2017. PMID: 28645622 - The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals.
Martorana F, Brambilla L, Valori CF, Bergamaschi C, Roncoroni C, Aronica E, Volterra A, Bezzi P, Rossi D. Martorana F, et al. Hum Mol Genet. 2012 Feb 15;21(4):826-40. doi: 10.1093/hmg/ddr513. Epub 2011 Nov 9. Hum Mol Genet. 2012. PMID: 22072391 - Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes.
Vargas MR, Johnson JA. Vargas MR, et al. Neurotherapeutics. 2010 Oct;7(4):471-81. doi: 10.1016/j.nurt.2010.05.012. Neurotherapeutics. 2010. PMID: 20880509 Free PMC article. Review. - Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis.
Pehar M, Vargas MR, Cassina P, Barbeito AG, Beckman JS, Barbeito L. Pehar M, et al. Neurodegener Dis. 2005;2(3-4):139-46. doi: 10.1159/000089619. Neurodegener Dis. 2005. PMID: 16909019 Review.
Cited by
- Why should we care about astrocytes in a motor neuron disease?
Stoklund Dittlau K, Van Den Bosch L. Stoklund Dittlau K, et al. Front Mol Med. 2023 Jan 23;3:1047540. doi: 10.3389/fmmed.2023.1047540. eCollection 2023. Front Mol Med. 2023. PMID: 39086676 Free PMC article. Review. - Recent advances in (patho)physiology of astroglia.
Verkhratsky A, Parpura V. Verkhratsky A, et al. Acta Pharmacol Sin. 2010 Sep;31(9):1044-54. doi: 10.1038/aps.2010.108. Epub 2010 Aug 9. Acta Pharmacol Sin. 2010. PMID: 20694024 Free PMC article. Review. - Why are astrocytes important?
Verkhratsky A, Nedergaard M, Hertz L. Verkhratsky A, et al. Neurochem Res. 2015 Feb;40(2):389-401. doi: 10.1007/s11064-014-1403-2. Epub 2014 Aug 12. Neurochem Res. 2015. PMID: 25113122 Review. - Human glial progenitor engraftment and gene expression is independent of the ALS environment.
Haidet-Phillips AM, Doreswamy A, Gross SK, Tang X, Campanelli JT, Maragakis NJ. Haidet-Phillips AM, et al. Exp Neurol. 2015 Feb;264:188-99. doi: 10.1016/j.expneurol.2014.12.011. Epub 2014 Dec 16. Exp Neurol. 2015. PMID: 25523812 Free PMC article. - Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis.
Baker DJ, Blackburn DJ, Keatinge M, Sokhi D, Viskaitis P, Heath PR, Ferraiuolo L, Kirby J, Shaw PJ. Baker DJ, et al. Front Cell Neurosci. 2015 Oct 15;9:410. doi: 10.3389/fncel.2015.00410. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26528138 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous